The isolation and characterization of glycosylated phosphoproteins from herring fish bones

Physical and chemical characteristics of Asian sea bass bio-calcium powders as affected by ultrasonication treatment and drying method

The effects of ultrasonication and drying method on particle size and other product characteristics of bio-calcium powder from Asian sea bass (Lates calcarifer) backbone were investigated. Ultrasonication was performed at different amplitudes (60%, 70%, and 80%) for varying periods (15 and 30 min). Ultrasonication at higher amplitudes for a longer time reduced the powder particle size more effectively (p < .05), but had no impact on zeta potential (p > .05). The bio-calcium powder ultrasonicated at 70% amplitude for 15 min had the smallest particle size (3.38 µm) when compared to the control (28.85 µm). When the ultrasonicated bio-calcium was subjected to drying, freeze-drying produced powders with higher calcium solubility but lower whiteness than hot air (tray) drying. The results suggest that the ultrasonication is a potential suitable method to reduce the size of bio-calcium powders, while the drying method slightly affected the product characteristics. The bio-calcium powder could serve as a suitable functional ingredient for food fortification aimed at improving the calcium bioavailability. Particle size of bio-calcium powder from fishbone could affect the mouth feel and calcium solubility when used for food product fortification. This work showed that ultrasonication could be used to obtain up to 10-fold reduction in the particle size of fishbone bio-calcium powders, which promotes increased calcium solubility when subjected to simulated gastrointestinal tract digestion. Few differences in characteristics of the bio-calcium powder were observed for freeze-dried and hot air-dried samples. Thus, an economical, safe, and fast process can be implemented for the production of small particle size bio-calcium powder from fishbone.

Effect of Alkaline Treatment on Characteristics of Bio-Calcium and Hydroxyapatite Powders Derived from Salmon Bone

Alkaline treatment has been extensively implemented in the extraction process of hydroxyapatite (HAp) extraction from various kinds of bio-materials, such as animal bone and scales. The main purpose of such treatment is to remove proteinaceous substances from raw materials. The influence of the alkaline treatment that could alter not only the organic contents but also chemical composition—specifically the Ca/P mole ratios of bio-calcium, HAp, and the biphasic apatite powders derived from salmon bone, a by-product from the salmon industry—was investigated. Both HAp and biphasic apatite powders were obtained from the calcination of bio-calcium powders with and without alkaline treatment, respectively. An X-ray diffraction analysis confirmed the presence of hydroxyapatite and β-tricalcium phosphate (β-TCP) in the calcined bone powder without alkaline treatment while only a single phase of hydroxyapatite was observed in the alkaline-treated sample. Calcium and phosphorus contents were measured by an inductively coupled plasma optical emission spectrometer (ICP-OES). A variation of Ca/P ratios was observed among all samples, depending on the chemical and heat treatment conditions. Organic molecules, such as protein, fat, hydroxyproline, and TBARS, were significantly lowered in bio-calcium powders with the alkaline treatment. This work represents important research on chemical treatment prior to the raw material conversion process, which significantly influences chemical and phase compositions of the bio-calcium and hydroxyapatite powder derived from salmon bone waste.

Quantitative gingival crevicular fluid proteome in health and periodontal disease using stable isotope chemistries and mass spectrometry

AIM

Application of quantitative stable isotope-labelling chemistries and mass spectrometry (MS) to determine alterations in gingival crevicular fluid (GCF) proteome in periodontal disease.

MATERIAL AND METHODS

Quantitative proteome of GCF from 40 healthy individuals versus 40 patients with periodontal disease was established using 320 GCF samples and stable isotope-labelling reagents, ICAT and mTRAQ, with MS technology and validated by enzyme-linked immunosorbent methods.

RESULTS

We have identified 238 distinct proteins of which 180 were quantified in GCF of both healthy and periodontal patients with additional 26 and 32 distinct proteins that were found only in GCF of healthy or periodontal patients. In addition, 42 pathogenic bacterial proteins and 11 yeast proteins were quantified. The data highlighted a series of proteins not quantified previously by large-scale MS approaches in GCF with relevance to periodontal disease, such as host-derived Ig alpha-2 chain C, Kallikrein-4, S100-A9, transmembrane proteinase 13, peptidase S1 domain, several collagen types and pathogenic bacterial proteins, e.g. formamidase, leucine aminopeptidase and virulence factor OMP85.

CONCLUSIONS

The innovative analytical approaches provided detailed novel changes in both host and microbial derived GCF proteomes of periodontal patients. The study defined 50 host and 16 pathogenic bacterial proteins significantly elevated in periodontal disease most of which were novel with significant potential for application in the clinical arena of periodontal disease.

Topographical distribution of phosphorylation sites of phosvitins by mass spectrometry

Phosvitin, derived from the vitellogenin II gene protein, is a highly phosphorylated protein found in egg yolk. A second hypothetical protein has been predicted based on the vitellogenin I gene, but has not been defined at the protein level. Mass spectrometric analysis was used to identify the phosphopeptide sequences and the precise sites of phosphorylation of two phosvitins, phosvitin 1 and phosvitin 2 derived from vitellogenins I and II, respectively. Samples of native phosvitin were subjected to tryptic digestion followed by mass spectrometric analysis: (i) native phosvitin peptides, (ii) after treatment with NaOH, and (iii) after chemical derivatization of P-Ser/P-Thr residues by dithiothreitol under base-catalyzed conditions. A combination of these approaches led to the identification of 68 and 35 phosphopeptides with 89 (81 P-Ser and 8 P-Thr residues) and 62 (57 P-Ser and 5 P-Thr residues) phosphorylation sites of phosvitin 1 and phosvitin 2, respectively. These data for the first time documented on a large scale the major states and sites of phosphorylation of phosvitins with a total of 151 phosphorylation sites. Importantly, the present work also provided the first direct de novo protein amino-acid sequence data for phosvitin 1 protein and evidence for the full expression of vitellogenin I gene.

BIOLOGICAL SIGNIFICANCE

We have for the first time generated a large number of phosphopeptides (~100) and identified 151 phosphorylation sites of phosvitin 1 and phosvitin 2, respectively. Importantly, this study also led to the discovery of a novel phosvitin 1 and provided the first direct de novo protein amino-acid sequence data for the full expression of vitellogenin I gene. There is considerable interest in naturally occurring phosphopeptides/phosphoproteins and their application in biomedical fields and in the food industry because of their molecular characteristics and non-toxic nature, hence, our work opens new avenues to pursue such endeavors. In addition, the results provide important fundamental biologic information relevant to evolutionary developments of vertebrate animals beginning with the earliest fish, reptiles, birds and more contemporary mammals. For instance, the abundance of phosvitins with a unique degree of phosphorylation in the egg yolk of fish, reptiles, and birds suggests potential biological functions of phosvitins which are critical to the development of embryos of these distant vertebrates.